Webinar presenters Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Morten Grauslund, PhD,Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark, discuss how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
This on-demand webinar was originally broadcast on April 28, 2026.
What will this webinar empower you to do?
• Understand how next-day CGP with the Oncomine Comprehensive Assay Plus on the Genexus System can help accelerate precision medicine research and biomarker discovery.
• Gain expert perspectives on expanding applications of CGP for broad molecular profiling across solid tumor and breast cancer research.
• Engage directly with molecular diagnostics and biomarker testing experts during a live, interactive Q&A session.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic procedures.